Bioreactor Actuated Ovarian Development
Bioreactor Actuated Ovarian Development
批准号:
7140670
负责人:
ALAN J RUSSELL
金额:
$20.93万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-09-15 至 2008-08-31
关键词:
alginatesapoptosisbasement membranebioengineering /biomedical engineeringbioreactorsbiotechnologycryopreservationcytologyfemalefertilitygene expressionglucose metabolismgraafian folliclesinsulininsulinlike growth factorlaboratory ratoogenesisorgan cultureovaryoxygen tensionshear stresstissue engineering
中文摘要
描述(由申请人提供):
卵泡是卵巢的基本单位,提供卵母细胞和雌性发育和生殖所需的类固醇激素。卵泡生长是一个长期的过程,涉及卵泡单位通过特定的组织学定义的发育阶段进行性发育。由于在过去的二十年里,新的不孕症治疗方法和人工生殖技术的出现,我们已经对晚期卵泡发育有了很好的了解。相比之下,我们对卵泡发育的早期阶段知之甚少。最近,世界各地的许多团体已经开始为年轻女孩和接受潜在绝育手术或化疗的妇女进行卵巢冷冻保存计划,希望卵泡可以从这些组织中分离出来,并在以后的日子里在体外生长,当妇女希望怀孕时。由于生长中的卵泡不能在冷冻后存活,因此冷冻保存后仅保留非常小的原始卵泡。虽然来自小鼠的卵泡可以使用传统的培养技术生长成熟,但科学家们在体外培养具有较大卵泡的物种(如大鼠,猪和人类)的卵泡方面一直不成功。因此,目前还没有技术可以利用这些保存的卵巢组织来研究卵泡发育,甚至恢复生育能力。我们最近进行了研究,以确定为什么大鼠卵泡不能在体外发展超过腔前卵泡阶段。我们的初步研究表明,在常规条件下,大鼠卵泡经常发生扁平化和破裂,失去解剖完整性,这对正常的卵子成熟过程很重要。当卵泡在悬浮培养系统中培养时,由轨道试管和内壁容器组成,卵泡不破裂,并表现出更健壮的生长。因此,我们相信,生物反应器技术的进步对开发一种能够支持卵泡发育的复杂需求的系统具有很大的希望。由于缺乏关于早期卵泡发育的知识,这是一个高风险的项目,因为反应器的设计必须是经验性的,而不是基于已知的生物学要求。我们提出,生物工程可以克服卵泡生长,并提供支持早期卵泡生长的解决方案,并建立健康卵泡发育的标志物,可用于微调培养条件,以获得优化的卵泡生长和发育。
英文摘要
DESCRIPTION (provided by applicant):
The follicle is the essential unit of the ovary, providing both oocytes and the steroid hormones necessary for female development and reproduction. Follicle growth is a prolonged process that involves progressive development of the follicle unit through specific histologically defined stages of development. Because of the advent of new infertility treatments and artificial reproductive technologies over the last two decades, we have built up an excellent understanding of late-stage follicle development. In contrast, we know very little about the earlier stages of follicle development. Recently many groups around the world have begun ovarian cryopreservation programs for young girls and women undergoing potentially sterilizing surgery or chemotherapy with the hope that follicles can be isolated from these tissues and grown in vitro at a later date, when the woman desires to become pregnant. Since growing follicles do not survive freezing, only the very small primordial follicles remain after cryopreservation. Though follicles derived from mice can be grown up to maturity using conventional culture techniques, scientists have been unsuccessful with the in vitro development of follicles from species that have larger follicles, such as rats, pigs and humans. Therefore there is no current technology in which these preserved ovarian tissues can be utilized to study follicle development or even to restore fertility. We have recently performed studies to determine why rat follicles fail to progress beyond the preantral follicle stage in vitro. Our preliminary studies demonstrated that under conventional conditions, rat follicles frequently undergo flattening and rupture with loss of anatomic integrity that is important to the normal egg maturation process. When follicles were cultured in suspension culture systems, consisting of orbiting test tubes and rotating-wall vessels, the follicles did not rupture and exhibited more robust growth. Therefore we believe that advances in bioreactor technologies hold great promise toward the development of a system that can support the complex needs of the developing follicle. The lack of knowledge surrounding early stage follicle development makes this a high-risk project because reactor design will have to be empirical rather than based on known biological imperatives. We propose that bioengineering can overcome empiricism and provide solutions that support the growth of early stage follicles and establish markers of healthy follicle development that can be used to fine tune culture conditions to obtain optimized follicle growth and development.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Bioreactor Actuated Ovarian Development
-
批准号:7036019
-
项目类别:
-
资助金额:$18.57万
-
财政年份:2005
-
负责人:ALAN J RUSSELL
-
依托单位:
Cellular Approaches to Tissue Engineering/Regeneration
-
批准号:6764026
-
项目类别:
-
资助金额:$35.06万
-
财政年份:2003
-
负责人:ALAN J RUSSELL
-
依托单位:
Cellular Approaches to Tissue Engineering/Regeneration
-
批准号:7226978
-
项目类别:
-
资助金额:$34.69万
-
财政年份:2003
-
负责人:ALAN J RUSSELL
-
依托单位:
Cellular Approaches to Tissue Engineering/Regeneration
-
批准号:6894682
-
项目类别:
-
资助金额:$35.06万
-
财政年份:2003
-
负责人:ALAN J RUSSELL
-
依托单位:
Cellular Approaches to Tissue Engineering/Regeneration
-
批准号:6660581
-
项目类别:
-
资助金额:$17.18万
-
财政年份:2003
-
负责人:ALAN J RUSSELL
-
依托单位:
Cellular Approaches to Tissue Engineering/Regeneration
-
批准号:7058788
-
项目类别:
-
资助金额:$35.06万
-
财政年份:2003
-
负责人:ALAN J RUSSELL
-
依托单位:
RACEMIC IBUPROFEN RESOLUTION IN SUPER CRITICAL CO2 USING CHIRAL RESOLVING AGENT
-
批准号:6221007
-
项目类别:
-
资助金额:$0.13万
-
财政年份:1999
-
负责人:ALAN J RUSSELL
-
依托单位:
ENANTIOMERIC RESOLUTION OF RACEMIC IBUPROFEN IN CO2 W/ CHIRAL RESOLVING AGENT
-
批准号:6282437
-
项目类别:
-
资助金额:$1.17万
-
财政年份:1998
-
负责人:ALAN J RUSSELL
-
依托单位:
ENANTIOMERIC RESOLUTION OF RACEMIC IBUPROFEN IN CO2 W/ CHIRAL RESOLVING AGENT
-
批准号:6122402
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1998
-
负责人:ALAN J RUSSELL
-
依托单位:
ENANTIOMERIC RESOLUTION OF RACEMIC IBUPROFEN IN CO2 W/ CHIRAL RESOLVING AGENT
-
批准号:6295092
-
项目类别:
-
资助金额:$1.17万
-
财政年份:1998
-
负责人:ALAN J RUSSELL
-
依托单位:
ENANTIOMERIC RESOLUTION OF RACEMIC IBUPROFEN IN SUPERCRITICAL CO2
-
批准号:6253495
-
项目类别:
-
资助金额:$0.61万
-
财政年份:1997
-
负责人:ALAN J RUSSELL
-
依托单位:
RACEMIC IBUPROFEN ENANTOMER RESOLUTION IN CO2: CHIRAL RESOLVING AGENT
-
批准号:5225229
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:ALAN J RUSSELL
-
依托单位:--
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
-
批准号:31970691
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:张胜萍
-
依托单位:
TM9SF4调控非小细胞肺癌细胞凋亡机制研究
-
批准号:31900527
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2019
-
负责人:孙磊
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
姜黄素与TRAIL的协同抗肿瘤机制研究
-
批准号:31101223
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2011
-
负责人:曹林
-
依托单位:
转凝蛋白通过线粒体凋亡途径致足细胞凋亡的机制研究
-
批准号:81100502
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2011
-
负责人:管娜
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位: